{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:23:31Z","timestamp":1768778611043,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"the Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["BMBF 01EO1504 MO.2 and MO.6"],"award-info":[{"award-number":["BMBF 01EO1504 MO.2 and MO.6"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00392-018-1285-4","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T06:52:49Z","timestamp":1527144769000},"page":"1111-1121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke\/TIA in Fabry disease patients without atrial fibrillation"],"prefix":"10.1007","volume":"107","author":[{"given":"Dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"M\u00fcntze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavian","family":"Maniuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gensler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Oder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Salinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nordbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"1285_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"1285_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/08035320510028076","volume":"94","author":"A Mehta","year":"2005","unstructured":"Mehta A, Ginsberg L (2005) Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr Suppl 94:24\u201327 (discussion 29 - 10)","journal-title":"Acta Paediatr Suppl"},{"key":"1285_CR3","doi-asserted-by":"publisher","first-page":"e010422","DOI":"10.1136\/bmjopen-2015-010422","volume":"6","author":"D Oder","year":"2016","unstructured":"Oder D, Uceyler N, Liu D, Hu K, Petritsch B, Sommer C, Ertl G, Wanner C, Nordbeck P (2016) Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y. BMJ Open 6:e010422","journal-title":"BMJ Open"},{"key":"1285_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","volume":"40","author":"K Sims","year":"2009","unstructured":"Sims K, Politei J, Banikazemi M, Lee P (2009) Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 40:788\u2013794","journal-title":"Stroke"},{"key":"1285_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236\u2013242","journal-title":"Eur J Clin Invest"},{"key":"1285_CR6","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781107239340","volume-title":"Textbook of stroke medicine","author":"M Brainin","year":"2014","unstructured":"Brainin M, Heiss W-D (2014) Textbook of stroke medicine. Cambridge University Press, Cambridge"},{"key":"1285_CR7","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.116.022802","volume":"134","author":"J Oldgren","year":"2016","unstructured":"Oldgren J, Hijazi Z, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L (2016) Performance and validation of a novel biomarker-based stroke risk score for atrial fibrillation. Circulation 134:1697\u20131707","journal-title":"Circulation"},{"key":"1285_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"1285_CR9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/jama.2015.10725","volume":"314","author":"L Melgaard","year":"2015","unstructured":"Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY (2015) Assessment of the CHA2DS2-VASc Score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. JAMA 314:1030\u20131038","journal-title":"JAMA"},{"key":"1285_CR10","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/ejhf.613","volume":"18","author":"S Ye","year":"2016","unstructured":"Ye S, Qian M, Zhao B, Buchsbaum R, Sacco RL, Levin B, Di Tullio MR, Mann DL, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Graham S, Labovitz AJ, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Lip GY, Thompson JL, Homma S (2016) CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm. Eur J Heart Fail 18:1261\u20131266","journal-title":"Eur J Heart Fail"},{"key":"1285_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijcard.2017.07.056","volume":"248","author":"SH Kang","year":"2017","unstructured":"Kang SH, Kim J, Park JJ, Oh IY, Yoon CH, Kim HJ, Kim K, Choi DJ (2017) Risk of stroke in congestive heart failure with and without atrial fibrillation. Int J Cardiol 248:182\u2013187","journal-title":"Int J Cardiol"},{"key":"1285_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"EC Jauch","year":"2013","unstructured":"Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44:870\u2013947","journal-title":"Stroke"},{"key":"1285_CR13","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL (2009) Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 40:2276\u20132293","journal-title":"Stroke"},{"key":"1285_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233\u2013270","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1285_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s10554-015-0711-1","volume":"31","author":"K Hu","year":"2015","unstructured":"Hu K, Liu D, Nordbeck P, Cikes M, Stork S, Kramer B, Gaudron PD, Schneider A, Knop S, Ertl G, Bijnens B, Weidemann F, Herrmann S (2015) Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosis. Int J Cardiovasc Imaging 31:1401\u20131412","journal-title":"Int J Cardiovasc Imaging"},{"key":"1285_CR16","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/eurheartj\/eht098","volume":"34","author":"J Kramer","year":"2013","unstructured":"Kramer J, Niemann M, Liu D, Hu K, Machann W, Beer M, Wanner C, Ertl G, Weidemann F (2013) Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J 34:1587\u20131596","journal-title":"Eur Heart J"},{"key":"1285_CR17","doi-asserted-by":"publisher","first-page":"pii:e002839","DOI":"10.1161\/JAHA.115.002839","volume":"5","author":"N Seydelmann","year":"2016","unstructured":"Seydelmann N, Liu D, Kramer J, Drechsler C, Hu K, Nordbeck P, Schneider A, Stork S, Bijnens B, Ertl G, Wanner C, Weidemann F (2016) High-sensitivity troponin: a clinical blood biomarker for staging cardiomyopathy in fabry disease. J Am Heart Assoc 5:pii:e002839","journal-title":"J Am Heart Assoc"},{"key":"1285_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","volume":"46","author":"E Kolodny","year":"2015","unstructured":"Kolodny E, Fellgiebel A, Hilz MJ, Sims K, Caruso P, Phan TG, Politei J, Manara R, Burlina A (2015) Cerebrovascular involvement in Fabry disease: current status of knowledge. Stroke 46:302\u2013313","journal-title":"Stroke"},{"key":"1285_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jns.2007.01.053","volume":"257","author":"DF Moore","year":"2007","unstructured":"Moore DF, Kaneski CR, Askari H, Schiffmann R (2007) The cerebral vasculopathy of Fabry disease. J Neurol Sci 257:258\u2013263","journal-title":"J Neurol Sci"},{"key":"1285_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, Kaneski CR (2008) Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab 95:163\u2013168","journal-title":"Mol Genet Metab"},{"key":"1285_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ymgme.2009.10.004","volume":"99","author":"SM Rombach","year":"2010","unstructured":"Rombach SM, Twickler TB, Aerts JM, Linthorst GE, Wijburg FA, Hollak CE (2010) Vasculopathy in patients with Fabry disease: current controversies and research directions. Mol Genet Metab 99:99\u2013108","journal-title":"Mol Genet Metab"},{"key":"1285_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.0954-6820.1947.tb06596.x","volume":"128","author":"AW Pompen","year":"1947","unstructured":"Pompen AW, Ruiter M, Wyers HJ (1947) Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal disease; two autopsy reports. Acta Med Scand 128:234\u2013255","journal-title":"Acta Med Scand"},{"key":"1285_CR23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D30TT696NJ","volume":"11","author":"JK Karen","year":"2005","unstructured":"Karen JK, Hale EK, Ma L (2005) Angiokeratoma corporis diffusum (Fabry disease). Dermatol Online J 11:8","journal-title":"Dermatol Online J"},{"key":"1285_CR24","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archderm.140.12.1440","volume":"140","author":"M Larralde","year":"2004","unstructured":"Larralde M, Boggio P, Amartino H, Chamoles N (2004) Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations. Arch Dermatol 140:1440\u20131446","journal-title":"Arch Dermatol"},{"key":"1285_CR25","volume-title":"Fabry disease: perspectives from 5 years of FOS","author":"O Lidove","year":"2006","unstructured":"Lidove O, Jaussaud R, Aractingi S (2006) Dermatological and soft-tissue manifestations of Fabry disease: characteristics and response to enzyme replacement therapy. In: Mehta A, Beck M, Sunder-Plassmann G (eds) Fabry disease: perspectives from 5 years of FOS. PharmaGenesis, Oxford"},{"key":"1285_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1346-8138.1995.tb03333.x","volume":"22","author":"M Yokota","year":"1995","unstructured":"Yokota M, Koji M, Yotsumoto S (1995) Histopathologic and ultrastructural studies of angiokeratoma corporis diffusum in Kanzaki disease. J Dermatol 22:10\u201318","journal-title":"J Dermatol"},{"key":"1285_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","volume":"79","author":"S Buechner","year":"2008","unstructured":"Buechner S, Moretti M, Burlina AP, Cei G, Manara R, Ricci R, Mignani R, Parini R, Di Vito R, Giordano GP, Simonelli P, Siciliano G, Borsini W (2008) Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry 79:1249\u20131254","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1285_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cca.2017.01.018","volume":"466","author":"C Auray-Blais","year":"2017","unstructured":"Auray-Blais C, Lavoie P, Boutin M, Ntwari A, Hsu TR, Huang CK, Niu DM (2017) Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation. Clin Chim Acta 466:185\u2013193","journal-title":"Clin Chim Acta"},{"key":"1285_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13023-016-0473-4","volume":"11","author":"M Lenders","year":"2016","unstructured":"Lenders M, Hennermann JB, Kurschat C, Rolfs A, Canaan-Kuhl S, Sommer C, Uceyler N, Kampmann C, Karabul N, Giese AK, Duning T, Stypmann J, Kramer J, Weidemann F, Brand SM, Wanner C, Brand E (2016) Multicenter Female Fabry Study (MFFS)\u2014clinical survey on current treatment of females with Fabry disease. Orphanet J Rare Dis 11:88","journal-title":"Orphanet J Rare Dis"},{"key":"1285_CR30","doi-asserted-by":"publisher","first-page":"e0166484","DOI":"10.1371\/journal.pone.0166484","volume":"11","author":"N Uceyler","year":"2016","unstructured":"Uceyler N, Schroter N, Kafke W, Kramer D, Wanner C, Weidemann F, Sommer C (2016) Skin Globotriaosylceramide 3 load is increased in men with advanced fabry disease. PLoS ONE 11:e0166484","journal-title":"PLoS ONE"},{"key":"1285_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00392-007-0566-0","volume":"97","author":"F Weidemann","year":"2008","unstructured":"Weidemann F, Strotmann JM (2008) Use of tissue Doppler imaging to identify and manage systemic diseases. Clin Res Cardiol 97:65\u201373","journal-title":"Clin Res Cardiol"},{"key":"1285_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00392-009-0084-3","volume":"99","author":"C Prinz","year":"2010","unstructured":"Prinz C, Farr M, Hering D, Horstkotte D, Faber L (2010) Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry\u2019s disease during enzyme-replacement therapy. Clin Res Cardiol 99:53\u201355","journal-title":"Clin Res Cardiol"},{"key":"1285_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00392-016-0989-6","volume":"105","author":"O Huttin","year":"2016","unstructured":"Huttin O, Marie PY, Benichou M, Bozec E, Lemoine S, Mandry D, Juilliere Y, Sadoul N, Micard E, Duarte K, Beaumont M, Rossignol P, Girerd N, Selton-Suty C (2016) Temporal deformation pattern in acute and late phases of ST-elevation myocardial infarction: incremental value of longitudinal post-systolic strain to assess myocardial viability. Clin Res Cardiol 105:815\u2013826","journal-title":"Clin Res Cardiol"},{"key":"1285_CR34","doi-asserted-by":"publisher","first-page":"e5338","DOI":"10.1097\/MD.0000000000005338","volume":"95","author":"FJ Olsen","year":"2016","unstructured":"Olsen FJ, Pedersen S, Jensen JS, Biering-Sorensen T (2016) Global longitudinal strain predicts incident atrial fibrillation and stroke occurrence after acute myocardial infarction. Medicine (Baltimore) 95:e5338","journal-title":"Medicine (Baltimore)"},{"key":"1285_CR35","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.echo.2012.02.003","volume":"25","author":"K Munk","year":"2012","unstructured":"Munk K, Andersen NH, Terkelsen CJ, Bibby BM, Johnsen SP, Botker HE, Nielsen TT, Poulsen SH (2012) Global left ventricular longitudinal systolic strain for early risk assessment in patients with acute myocardial infarction treated with primary percutaneous intervention. J Am Soc Echocardiogr 25:644\u2013651","journal-title":"J Am Soc Echocardiogr"},{"key":"1285_CR36","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1161\/hc4201.097944","volume":"104","author":"P Verdecchia","year":"2001","unstructured":"Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G (2001) Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 104:2039\u20132044","journal-title":"Circulation"},{"key":"1285_CR37","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1161\/01.STR.0000078310.98444.1D","volume":"34","author":"G Selvetella","year":"2003","unstructured":"Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, Trimarco B, Colonnese C, Lembo G (2003) Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke 34:1766\u20131770","journal-title":"Stroke"},{"key":"1285_CR38","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.04.044","volume":"24","author":"WT O\u2019Neal","year":"2015","unstructured":"O\u2019Neal WT, Almahmoud MF, Qureshi WT, Soliman EZ (2015) Electrocardiographic and echocardiographic left ventricular hypertrophy in the prediction of stroke in the elderly. J Stroke Cerebrovasc Dis 24:1991\u20131997","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1285_CR39","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/hr.2014.88","volume":"37","author":"S Wang","year":"2014","unstructured":"Wang S, Xue H, Zou Y, Sun K, Fu C, Wang H, Hui R (2014) Left ventricular hypertrophy, abnormal ventricular geometry and relative wall thickness are associated with increased risk of stroke in hypertensive patients among the Han Chinese. Hypertens Res 37:870\u2013874","journal-title":"Hypertens Res"},{"key":"1285_CR40","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.jacc.2008.09.014","volume":"52","author":"DA Bluemke","year":"2008","unstructured":"Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR (2008) The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 52:2148\u20132155","journal-title":"J Am Coll Cardiol"},{"key":"1285_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2013.08.710","volume":"25","author":"T Hojs Fabjan","year":"2014","unstructured":"Hojs Fabjan T, Hojs R (2014) Stroke and renal dysfunction. Eur J Intern Med 25:18\u201324","journal-title":"Eur J Intern Med"},{"key":"1285_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00392-015-0948-7","volume":"105","author":"G Andrikopoulos","year":"2016","unstructured":"Andrikopoulos G, Tzeis S, Terentes-Printzios D, Varounis C, Vlachopoulos C, Mantas I, Patsilinakos S, Lampropoulos S, Olympios C, Kartalis A, Manolis A, Gotsis A, Triposkiadis F, Tsaknakis T, Goudevenos I, Kaprinis I, Pras A, Vasiliou F, Skoumpourdis E, Sakka G, Draganigos A, Vardas P (2016) Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis. Clin Res Cardiol 105:518\u2013526","journal-title":"Clin Res Cardiol"},{"key":"1285_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00392-015-0928-y","volume":"105","author":"T Zeus","year":"2016","unstructured":"Zeus T, Ketterer U, Leuf D, Dannenberg L, B\u00f6nner F, Wagstaff R, Gliem M, Jander S, Kelm M, Polzin A (2016) Safety of percutaneous coronary intervention in patients with acute ischemic stroke\/transient ischemic attack and acute coronary syndrome. Clin Res Cardiol 105:356\u2013363","journal-title":"Clin Res Cardiol"},{"key":"1285_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00392-017-1193-z","volume":"107","author":"KM Fox","year":"2017","unstructured":"Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U (2017) Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins. Clin Res Cardiol 107:380\u2013388 (Epub ahead of print)","journal-title":"Clin Res Cardiol"},{"key":"1285_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00392-015-0919-z","volume":"105","author":"A Yadlapati","year":"2016","unstructured":"Yadlapati A, Groh C, Malaisrie SC, Gajjar M, Kruse J, Meyers S, Passman R (2016) Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves. Clin Res Cardiol 105:268\u2013272","journal-title":"Clin Res Cardiol"},{"key":"1285_CR46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00392-015-0910-8","volume":"105","author":"J Seeger","year":"2016","unstructured":"Seeger J, Bothner C, Dahme T, Gonska B, Scharnbeck D, Markovic S, Rottbauer W, W\u00f6hrle J (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225\u2013229","journal-title":"Clin Res Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1285-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1285-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1285-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T02:38:23Z","timestamp":1661308703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1285-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1285-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,24]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"P. Nordbeck, C. Wanner and F. Weidemann received speaker and\/or advisory board honoraria from Amicus, Genzyme and Shire corporations. Research grants were given to the Institution by Genzyme and Shire corporations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}